Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States

By sjmartinez • February 21, 2025

Pak K, Sachar R, Saab S. Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States. Dig Dis Sci. 2025 Feb 20. doi: 10.1007/s10620-025-08909-z. Epub ahead of print. PMID: 39979574.

Tags: Digestive Diseases, Gray zone, HCC, hepatitis B, Immune-tolerant, Publications

Reducing demographic bias in biomedical machine learning for cancer detection using cfDNA methylation

Li S, Zeng W, Li W, Liu CC, Zhou Y, Ni X, Stackpole ML, Yeh AH, Melehy A, Lu DS, Raman SS, Hsu W, Mishra[...]

Migraine to Mesenteric Mishap: A Case Report of Ischemic Colitis Due to Sumatriptan

Quon MG, Kokoy-Mondragon C, Quon CM. Migraine to Mesenteric Mishap: A Case Report of Ischemic Colitis Due to Sumatriptan. Cureus. 2026 Jan 22;18(1):e102093. doi: 10.7759/cureus.102093.[...]

Gut Check: Gastrointestinal Tuberculosis as a Potential Mimic of Another Disease

Harmon RL, Baniqued M, Hong S, Tan H, Kovacs T, Chandna S. Gut Check: Gastrointestinal Tuberculosis as a Potential Mimic of Another Disease. Cureus. 2026[...]